Naor Nir - Insider Non-Derivative Transactions at BRAINSTORM CELL THERAPEUTICS INC. (BCLI) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 19, 2023, Naor Nir's relationship to BRAINSTORM CELL THERAPEUTICS INC. (BCLI) is Director, and currently has 11,999 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other BCLI insiders.
Data Source: SEC.
Naor Nir - Insider Non-Derivative Transactions at BCLI
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 20, 2023 | Acquisition -- (Common Stock) | 11999 | 0 | 11999 |